<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9969">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05686395</url>
  </required_header>
  <id_info>
    <org_study_id>IRB0010038</org_study_id>
    <nct_id>NCT05686395</nct_id>
  </id_info>
  <brief_title>Pain Control After Arthroscopic Shoulder Surgeries</brief_title>
  <official_title>Comparative Study of Analgesic Efficacy of Ultrasound Guided Interscalene Block Versus Combined Shoulder Anterior Capsular Block and Suprascapular Nerve Block for Arthroscopic Shoulder Surgeries.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted to compare the perioperative analgesic efficacy of ultrasound -&#xD;
      guided interscalene brachial plexus block versus combined shoulder anterior capsular block&#xD;
      and anterior suprascapular nerve block for arthroscopic shoulder surgeries.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2023</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>post operative analgesic consumption</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>The first 24 hours post operative analgesic consumption</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue score (VAS) in the first 24 hours after surgery</measure>
    <time_frame>first 24 hours after surgery</time_frame>
    <description>- Postoperative pain intensity will be assessed in the first 24 hour using VAS score where (0 = no pain and 100 = the worst imaginable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score</measure>
    <time_frame>first 24 hours after surgery</time_frame>
    <description>Patient satisfaction score will be assessed on the basis of a questionnaire and graded on a 4-point scale (excellent/good/fair/poor).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of hemi diaphragmatic paralysis</measure>
    <time_frame>immediately before block and immediately after procedure</time_frame>
    <description>hemidiaphragmatic paralysis after block</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Post Operative Pain</condition>
  <arm_group>
    <arm_group_label>group 1 Ultrasound-guided Interscalene Block group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In this group, ultrasound-guided ISB will be done using 10 ml of bupivacaine 0.25%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group 2 Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>, ultrasound-guided SHAC block will be done using 10 ml of bupivacaine 0.25% injected in the interfacial plane between deltoid and subscapular muscle and 10 ml of bupivacaine 0.25% injected in the pericapsular space. Ultrasound-guided SSN block will be done using 10 ml of bupivacaine 0.25% injected at sub omohyoid space.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound-guided Interscalene Block group</intervention_name>
    <description>ultrasound guided interscalene block versus combined ultrasound guided shoulder anterior capsular block and suprascapular nerve block for arthroscopic shoulder surgery</description>
    <arm_group_label>group 1 Ultrasound-guided Interscalene Block group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block</intervention_name>
    <description>Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block</description>
    <arm_group_label>group 2 Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>bupivacaine 0.25%.</description>
    <arm_group_label>group 1 Ultrasound-guided Interscalene Block group</arm_group_label>
    <arm_group_label>group 2 Combined Ultrasound guided shoulder anterior capsular block and suprascapular nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 20-65 years of both sexes, with American Society of Anesthesiologists&#xD;
             (ASA) physical status I or II admitted for arthroscopic shoulder surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal.&#xD;
&#xD;
          -  Uncooperative patient.&#xD;
&#xD;
          -  Patient with neurological deficit.&#xD;
&#xD;
          -  Patients with respiratory disorders.&#xD;
&#xD;
          -  Patient with bleeding disorders.&#xD;
&#xD;
          -  Infection at the block injection site.&#xD;
&#xD;
          -  Patients with history of allergy to local anesthetics.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>HOSAMELDIN ELDIB, MASTER</last_name>
    <phone>00201000504087</phone>
    <email>dr.semsem337@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine Tanta University</name>
      <address>
        <city>Tanta</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>hosameldin eldib, master</last_name>
      <phone>00201000504087</phone>
      <email>dr.semsem337@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2023</verification_date>
  <study_first_submitted>January 6, 2023</study_first_submitted>
  <study_first_submitted_qc>January 13, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2023</study_first_posted>
  <last_update_submitted>January 13, 2023</last_update_submitted>
  <last_update_submitted_qc>January 13, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 17, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Hosameldin Ibrahim Ibrahim Elsayed Eldib</investigator_full_name>
    <investigator_title>ASSISTANT LECTURER OF ANESTHESIA AND INTENSIVE CARE AND PAIN MEDICINE</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

